openPR Logo
Press release

Respiratory Disease Testing Market Projected to Register 3.40% CAGR through 2022

03-13-2018 12:21 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Respiratory Disease Testing Market Projected to Register 3.40%

The presence of large pool of players points towards a high competitive business landscape in the global respiratory disease testing market, states a new study by Transparency Market Research (TMR). The leading companies, such as GE Healthcare, Cosmed, Philips Healthcare, and CareFusion Corp., are actively investing in research activities to accelerate the development of novel and technologically advanced respiratory disease testing devices and solutions. Hitherto, players have been relying upon technology for their growth; however, a shift in their focus is anticipated in the near future towards strategic collaborations to strengthen their positions in this market, reports the study.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288

As per TMR, the opportunity in the worldwide market for respiratory disease testing was US$2.32 bn in 2013. Expanding at a CAGR of 3.40% during the period from 2014 to 2022, the market is likely to reach a value of US$3.1 mn by the end of the forecast period. Respiratory disease testing solutions find significant application in hospitals, clinical laboratories, and physicians’ clinics. Hospitals have emerged as the leading end user of these solutions and are expected to remain so over the next few years. Currently, the demand for imaging test is much higher than other types of tests for the detection of respiratory diseases. Researchers anticipate this trend to continue in the near future.

Regionally, the global respiratory disease testing market reports its presence across the Middle East and Africa, Latin America, Asia Pacific, North America, and Europe. North America led the global market in 2013 and is projected to retain its dominance over the period of the forecast, states the research report.

Request for TOC @ https://www.transparencymarketresearch.com/report-toc/1288

Significant Rise in Respiratory Disease Cases to Boost Market’s Growth

“The significant rise in the prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and cystic fibrosis, is the main factor behind the constant growth of the global market for respiratory disease testing,” states the author of the study. Since early detection of these diseases assist in effective treatment, the demand for respiratory disease testing solutions is continually increasing, reflecting greatly on this market.

The rise in the population of elderly people, prone to respiratory problems, are also supporting the market’s progress remarkably. The technological advancements in these devices and solutions are projected to boost this market in the years to come, reports the study.

Low Adoption Rate of Respiratory Disease Testing devices to Pose Challenges

In spite of the high demand for respiratory disease testing solutions across the world, the market may face significant challenges from the low adoption rate of portable spirometers and digital radiography among masses over the forthcoming years. The high cost of these testing devices are also projected to create hindrances in the market’s growth trajectory in the near future.

Nonetheless, the increasing governmental support, in terms of funding, for research and development and the escalating number of awareness programs are anticipated to keep the market going over the forecast period, states the report.

Obtain Report Details @ https://www.transparencymarketresearch.com/respiratory-disease-testing.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Disease Testing Market Projected to Register 3.40% CAGR through 2022 here

News-ID: 976422 • Views: 131

More Releases from Transparency Market Research

Dielectric Gases Market Shares, Strategies and Opportunities 2027
Overview TMR’s report on the Dielectric Gases Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Dielectric Gases market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Dielectric Gases market over the
Oxalic Acid Market Size will Observe Lucrative Surge by the End 2027
Overview TMR’s report on the Oxalic Acid Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Oxalic Acid market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Oxalic Acid market over the
Long Fiber Thermoplastics Market Shares, Strategies and Opportunities 2027
Overview TMR’s report on the Long Fiber Thermoplastics Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Long Fiber Thermoplastics market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Long Fiber Thermoplastics
High Performance Foaming Agents Market Size will Observe Lucrative Surge by the …
Overview TMR’s report on the High Performance Foaming Agents Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the High Performance Foaming Agents market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the High

All 5 Releases


More Releases for Respiratory

Global Respiratory Protection Equipment Market Research Report
This report studies the global Respiratory Protection Equipment market status and forecast, categorizes the global Respiratory Protection Equipment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 3M Avon Protection Systems Bullard Group Honeywell International MSA Safety Alpha Pro Tech Ansell
Respiratory Inhalers Market - Global Industry Analysis 2025
Chronic respiratory diseases are the group of chronic diseases which affect airways, lungs and the other parts of respiratory system. Chronic respiratory disease include asthma and respiratory allergies, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Diseases, Sleep Apnoea Syndrome and Pulmonary Hypertension. However 70% chronic respiratory disease are asthma and chronic obstructive pulmonary disease. In 2012, globally, 1 billion people are affected with chronic respiratory disease and account for 7%
Respiratory Monitoring Devices Industry Trends
Global Respiratory Monitoring Devices Market: Snapshot Factors at the forefront of driving the demand in the global respiratory monitoring devices market are the rising number of cigarette smokers and a worsening air quality on account of rampant pollution. Further, a burgeoning geriatric population highly susceptible to lung diseases has also pushed up the demand in the market. Countering its growth, however, are the steep prices of newer, sophisticated respiratory monitoring devices,
Respiratory Monitoring Devices Market 2015
While a handful players have taken up a majority share in the global distribution of respiratory monitoring devices, the remainder of the market is marked by a very large number of small players. Of the key multinationals dominating the distribution of respiratory monitoring devices in 2014, CareFusion Corporation, Smiths Medical, and ResMed, Inc., had garnered a total share of 54.2% in terms of value. As described in a research report released
5th Global Respiratory and Pulmonologist Annual Meeting
Pulmonology » | Pulmonology Conference » | Respiratory Congress » | Pulmonologists Meeting » | COPD Conference » On behalf of the Conference Organizing Committee, it is with great pleasure that we welcome you to the official website of 5th Global Respiratory and Pulmonologist Annual Meeting during November 17-18, 2016 at Dubai, UAE. Conference Theme: Optimizing Research strategies & Neoteric developments in Pulmonary Disorders Respiratory disorders is a medical terminology which includes
Respiratory Distress in Premature Infants
FOR IMMEDIATE RELEASE New York, NY:Respiratory distress syndrome (RDS) is a breathing condition common in premature infants whose lungs have not fully developed yet. The earlier the birth in gestational time, the more prone the infant is to RDS and the more severe it is likely to be. Fully developed lungs are coated with a naturally occurring slippery substance called surfactant. Surfactant lines the air sacs in the lungs and reduces surface